Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Stimulant Use: early-phase trial registry
6 of 7 indexed Stimulant Use trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 6 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Stimulant Use: 7 US clinical trials tracked, 6 recruiting.
Stimulant Use is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Florida International University, running 1 of these trials.
Enrollment posture brief
Registry condition stimulant-use
OPEN 6 | RECR 86% | LATE 0 | EARLY 1 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenovirus (86% recruiting · 7 trials)
Stimulant Use lists 6 open slots (86% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Stimulant Use on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Stimulant Use is recruiting above its size-band peers.
6 of 7 indexed trials (85.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Stimulant Use trials is spread across many organizations.
Florida International University accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Stimulant Use trials plan to enrol fewer than 100 people.
Median target enrolment is 80 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Stimulant Use research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Project neuroARTEMIS
Wake Forest University Health Sciences
NCT06814275
Enhancing Prospective Thinking in Early Recovery
Indiana University
NCT05835921
Neuromodulation and Cognitive Training for Substance Use Disorders
University of Minnesota
NCT04426214
rTMS for Craving in Methamphetamine Use Disorder
Oregon Health and Science University
NCT03470480
Accelerated rTMS for Substance Use Disorder and Depression
University of Texas Southwestern Medical Center
NCT06424184
Acute Effects of Stimulant Medication in College Students With ADHD
University of Wyoming
NCT03935646
PrEP Affect Regulation Treatment Innovation
Florida International University
NCT04899024
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Stimulant Use records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Stimulant Use trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Stimulant Use page
7 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Stimulant Use trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Florida International University sponsors the most Stimulant Use trials on record, review their full trial history before evaluating a specific study. See Florida International University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stimulant Use condition card totals 7 registered trials; most-linked intervention Contingency Management for PrEP Adherence; top US site state Wyoming. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.